AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise

Amedisys, Inc. (AMED) reported first-quarter 2025 adjusted earnings per share (EPS) of $1.25, which rose 21.4% year over year. The metric surpassed the Zacks Consensus Estimate by 10.6%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) GAAP EPS was $1.84 compared with 44 cents in the corresponding period of 2024. The earnings report, however, did not have any immediate impact on the company's share price of $93.63. AMED's Q1 Revenues The quarter's adjustments include certain merger- ...